VBI Vaccines Inc. Stock price Toronto S.E.
Equities
VBV
CA91822J1030
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.82 CAD | -5.12% | -7.66% | -10.58% |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
Mar. 18 | North American Morning Briefing : Investors -2- | DJ |
Sales 2023 * | 13M 17.61M | Sales 2024 * | 20M 27.09M | Capitalization | 14.27M 19.33M |
---|---|---|---|---|---|
Net income 2023 * | -98M -133M | Net income 2024 * | -21M -28.44M | EV / Sales 2023 * | 1.1 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.71 x |
P/E ratio 2023 * |
-0.09
x | P/E ratio 2024 * |
-0.73
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 84.98% |
1 day | -5.12% |
Managers | Title | Age | Since |
---|---|---|---|
Jeff Baxter
CEO | Chief Executive Officer | 62 | 16-04-30 |
Nell Beattie
DFI | Director of Finance/CFO | 36 | 15-07-08 |
David Anderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 16-05-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 23-04-23 |
Steven Gillis
CHM | Chairman | 70 | 04-12-31 |
Jeff Baxter
CEO | Chief Executive Officer | 62 | 16-04-30 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
-8.77% | 11.06B |
- Stock
- Equities
- Stock VBI Vaccines Inc.
- Stock VBI Vaccines Inc. - Toronto S.E.